DPIIT recognised startup Government of India
Startup India
Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals Private Limited - chemicals in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.43 Cr
▲ 152% YoY
Net profit · FY 2024
₹10.18 Lakh
Net margin 7.1%
EBITDA · FY 2024
₹12.74 Lakh
EBITDA margin 8.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹36 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Blyners Pharmaceuticals Private Limited
Data last updated:
Blyners Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India, recognised as a startup by DPIIT. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 27 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2018PTC313085.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajendra Bhausaheb Jadhav and Yogesh Bhausaheb Jadhav.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House Number.159 A/P – Katarni Tal – Yeola, Nashik, Maharashtra, India – 423104.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.43 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.18 Lakh (net margin 7.1%) and EBITDA of ₹12.74 Lakh (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
As per MCA filings, the company has open charges of ₹36 Lakh on record.
Blyners Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0040721).
Company Details of Blyners Pharmaceuticals Private Limited
CIN U24290MH2018PTC313085
Registration Number 313085
Incorporation Date 27 August 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0040721
Key People
Rajendra Bhausaheb Jadhav Director Yogesh Bhausaheb Jadhav Director Netra Yogesh Jadhav Director Recognitions & Rankings of Blyners Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-23-0040721
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse Number.159 A/P – Katarni Tal – Yeola, Nashik, Maharashtra, India – 423104
- IndustryChemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Blyners Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Blyners Pharmaceuticals Private Limited
The main business activity of Blyners Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Blyners Pharmaceuticals Private Limited FY 2025 filings available
Blyners Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 152% YoY) for FY 2024.
Revenue · FY 2024
₹1.43 Cr ▲ 152%
Net profit · FY 2024
₹10.18 Lakh margin 7.1%
EBITDA · FY 2024
₹12.74 Lakh margin 8.9%
Compounded Annual Growth Rate (CAGR) of Blyners Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 152%
3 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 285%
3 years · compounded
▲ 39%
5 years · compounded
▲ 98%
Revenue has grown at a compounded annual rate (CAGR) of 33% over three years, including 152% growth in the latest year. EBITDA rose 285% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Blyners Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.74 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Blyners Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Blyners Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Bhausaheb Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
| Yogesh Bhausaheb Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
| Netra Yogesh Jadhav | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
Peer Comparison of Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Voc&Loc Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Chandigarh, India |
| Zelaino Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Solapur, Maharashtra, India |
| Megaclite Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2023) | •••• | •••• | 23.0% | •••• | Gandipet, Telangana, India |
| Accumont Pharmaceuticals (OPC) Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| Udai Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | 75.0% | •••• | Delhi, India |
| Blyners Pharmaceuticals Private Limited this company | ₹1.43 Cr (FY 2024) | •••• | •••• | 152.0% | •••• | Nashik, Maharashtra, India |
| Cassopeia Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Panchkula, Haryana, India |
| Vanmart Pharmaceuticals and Biotech Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Raipur, Chhattisgarh, India |
| Seamac India Pharmaceuticals Private Limited | ₹1.42 Cr (FY 2024) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Alex Pharmaceuticals Pvt Ltd | ₹1.42 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Ahmedabad, Gujarat, India |
| Paradox India Pharmaceuticals Private Limited | ₹1.42 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Tamluk, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Blyners Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Blyners Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Blyners Pharmaceuticals Private Limited
Open charges
₹36 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2022 | Axis Bank Limited | ₹36 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Blyners Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Blyners Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Netra Yogesh Jadhav was appointed as Director on 27 Aug 2018.
AGM
Blyners Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 36.00 Lakh registered on 24 Aug 2022 with Charge ID 100609258 was modified on 14 May 2025.
Filing
Blyners Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.00 Lakh with Charge ID 100609258 was registered on 24 Aug 2022.
Appointed
Netra Yogesh Jadhav was appointed as Director.
Appointed
Rajendra Bhausaheb Jadhav was appointed as Director.
Appointed
Yogesh Bhausaheb Jadhav was appointed as Director.
Incorporation
27 Aug 2018
Blyners Pharmaceuticals Private Limited was registered on 27 Aug 2018 with Roc Mumbai & aged 8 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Blyners Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Blyners Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Blyners Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Blyners Pharmaceuticals Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Blyners Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Blyners Pharmaceuticals Private Limited
Blyners Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 27 August 2018 (8+ years old) and is registered under CIN U24290MH2018PTC313085.
Blyners Pharmaceuticals reported revenue of ₹1.43 Cr for FY 2024 (up 152% YoY).
Blyners Pharmaceuticals has 3 current directors:
- Rajendra Bhausaheb Jadhav - Director
- Yogesh Bhausaheb Jadhav - Director
- Netra Yogesh Jadhav - Director
Blyners Pharmaceuticals reported a net profit of ₹10.18 Lakh (net margin 7.1%) and EBITDA of ₹12.74 Lakh (EBITDA margin 8.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Blyners Pharmaceuticals is 33% over three years. In the latest year (FY 2024) revenue rose 152%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Blyners Pharmaceuticals is U24290MH2018PTC313085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blyners Pharmaceuticals was incorporated on 27 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Blyners Pharmaceuticals by revenue are Voc&Loc Pharmaceuticals Private Limited, Zelaino Pharmaceuticals Private Limited, Megaclite Pharmaceuticals Private Limited, Accumont Pharmaceuticals (OPC) Private Limited, Udai Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Netra Yogesh Jadhav was appointed as Director on 27 Aug 2018. Rajendra Bhausaheb Jadhav was appointed as Director on 27 Aug 2018. Yogesh Bhausaheb Jadhav was appointed as Director on 27 Aug 2018.
Yes, Blyners Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Blyners Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0040721).